2023
DOI: 10.1002/npr2.12363
|View full text |Cite
|
Sign up to set email alerts
|

Highly endorsed screening and assessment scales for alcohol problems: A systematic review

Abstract: BackgroundProblems associated with alcohol use are multidimensional with psychiatric, psychological, physical, and social aspects, which makes it challenging to choose appropriate assessment scales. However, there has been no systematic evaluation of existing alcohol scales.MethodsA systematic literature search was conducted for articles that assessed the psychometric properties of scales for alcohol use disorder on March 19, 2023, using Medline, EMBASE, and PsycINFO. Only scales whose original development pap… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 56 publications
0
1
0
Order By: Relevance
“…There is not yet wide agreement on one or a few standard simple clinical measures that clinicians and patients could use to either personalize dose adjustments or inform treatment decision-making in the management of each patient. This stands in contrast to the use of scaled measures for alcohol use [ 22 , 23 ], and many other mental health, neuropsychiatric and general medical conditions, where treatment outcomes are scaled [ 24 ]. In OUD treatment trials, domains that are typically measured include: retention in treatment, illicit opioid use as determined by urine toxicology, opioid craving, and global ratings by patient and staff [ 1 ].…”
Section: Introductionmentioning
confidence: 99%
“…There is not yet wide agreement on one or a few standard simple clinical measures that clinicians and patients could use to either personalize dose adjustments or inform treatment decision-making in the management of each patient. This stands in contrast to the use of scaled measures for alcohol use [ 22 , 23 ], and many other mental health, neuropsychiatric and general medical conditions, where treatment outcomes are scaled [ 24 ]. In OUD treatment trials, domains that are typically measured include: retention in treatment, illicit opioid use as determined by urine toxicology, opioid craving, and global ratings by patient and staff [ 1 ].…”
Section: Introductionmentioning
confidence: 99%